CLYM
Climb Bio
CLYM
CLYM
43 hedge funds and large institutions have $146M invested in Climb Bio in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 19 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
20% less capital invested
Capital invested by funds: $182M → $146M (-$35.7M)
68% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 19
Holders
43
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.58M | |
| 2 | +$1.19M | |
| 3 | +$154K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$133K |
| 5 |
PL
Parkwood LLC
Cleveland,
Ohio
|
+$88.3K |
Top Sellers
| 1 | -$1.74M | |
| 2 | -$1.25M | |
| 3 | -$785K | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$611K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$494K |